ロード中...
Bone marrow donor selection and characterization of MSCs is critical for pre-clinical and clinical cell dose production
BACKGROUND: Cell based therapies, such as bone marrow derived mesenchymal stem cells (BM-MSCs; also known as mesenchymal stromal cells), are currently under investigation for a number of disease applications. The current challenge facing the field is maintaining the consistency and quality of cells...
保存先:
| 出版年: | J Transl Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6469059/ https://ncbi.nlm.nih.gov/pubmed/30995929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-1877-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|